Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.17 | 0.001 |
mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.094 | 0.002 |
mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.003 |
mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.003 |
mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.14 | 0.003 |
mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.005 |
mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |